Immunotherapy in cholangiocarcinoma: From concept to clinical trials
Cholangiocarcinoma (CCA) is an epithelial malignancy of the bile tract that has a poor prognosis and lacks effective treatments. The first-line systemic therapy for CCA patients is gemcitabine combined with cisplatin, and the efficacy and safety of immunotherapies are still unclear. The special tumo...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-06-01
|
| Series: | Surgery in Practice and Science |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666262021000036 |